XOMA ROYALTY CORPORATION EFFE COM USD0.0075(POST REV SPLT)XOMA ROYALTY CORPORATION EFFE COM USD0.0075(POST REV SPLT)XOMA ROYALTY CORPORATION EFFE COM USD0.0075(POST REV SPLT)

XOMA ROYALTY CORPORATION EFFE COM USD0.0075(POST REV SPLT)

No trades
See on Supercharts

0M26 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

XOMA Royalty Corp. operates as a biotech royalty aggregator, which engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets that provides right to future potential royalty and milestone payments. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
0M26 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company